Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - CAPITAL EXPENDITURES
Capital Expenditures ALNY - Alnylam Pharmaceuticals, Inc.
-34.3 M
LAST VALUE
31.03%
2 YEAR CAGR
24.55%
5 YEAR CAGR
-14.36%
10 YEAR CAGR